• 2003

Company Description

Cleveland BioLabs is focused on oncology and orphan drug development.

Cleveland BioLabs (Nasdaq:CBLI) is a biotechnology company leveraging its proprietary discoveries around programmed cell death to develop a robust pipeline of drugs for multiple medical and defense applications.